SCHEMBL30065759

SCHEMBL30065759

c1ccc(Nc2cncc(-c3cccc4cc[nH]c34)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 2/20 0.41
▸ SLC22A12 Q96S37 2/20 0.41
▸ PIK3CA P42336 1/20 0.40
▸ HPGDS O60760 3/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ PRKCQ Q04759 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ AXL P30530 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ PDPK1 O15530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3925398 0.76 L3MBTL1 (0.44) PIK3CAHPGDSKDRKDM4EALDH1A1
SCHEMBL20552273 0.76 GRM5 (0.56) KDRALDH1A1CYP3A4CDK8
SCHEMBL31527594 0.76 KEAP1 (0.49) HPGDSKDM4EALDH1A1HPGDHSD17B10
SCHEMBL21771077 0.74 HPGDS (0.47) HPGDSKDM4EALDH1A1HPGDCDK8
SCHEMBL20553716 0.73 HPGDS (0.52) HPGDS
SCHEMBL594405 0.73 AHR (0.50) KDRAHRPDPK1REN
SCHEMBL30065768 0.73 XDH (0.48) XDHSLC22A12KDM4EALDH1A1CYP3A4
SCHEMBL23164297 0.72 CDK1 (0.40) CDK1KDRKDM4ECYP3A4
SCHEMBL4192415 0.71 XDH (0.59) XDHSLC22A12ALDH1A1HSD17B10CHRNB4
SCHEMBL20552457 0.71 TRPV1 (0.50) HPGDSCDK8SIRT2SIRT1SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2025-07-08 — — US disclosed
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN CENTRE HOSPITALIER UNIVERSITAIRE DE CLERMONT-FD (FR) 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363643-A1 NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN P2RX3, OPRL1, P2RX6 XDH 1051/4885SLC22A12 3909/4885PIK3CA 3237/4885
US-12351556-B2 Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain P2RX3, P2RX6, P2RX4 XDH 938/4885SLC22A12 3755/4885PIK3CA 3113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback